Jeffrey Bluestone

Dr. Jeffrey Bluestone, PhD, is a distinguished figure in the field of immunology, holding the A.W. and Mary Margaret Clausen Distinguished Professorship in Metabolism and Endocrinology at the University of California, San Francisco (UCSF). As the Director of the Hormone Research Institute within the Diabetes Center, Dr. Bluestone has dedicated over 25 years to pioneering research in T cell activation and immune tolerance, particularly in the context of autoimmunity and organ transplantation. Dr. Bluestone's research has been instrumental in the development of innovative immunotherapies that target regulatory T cells, offering new hope for patients with autoimmune diseases and those undergoing organ transplantation. His work is characterized by a deep commitment to translating basic scientific discoveries into clinical applications, thereby improving patient outcomes. With an impressive portfolio of over 300 peer-reviewed publications, Dr. Bluestone's contributions to the field have been widely recognized. His research excellence has been acknowledged through numerous awards, underscoring his impact on advancing our understanding of immune mechanisms and therapeutic interventions. In addition to his research endeavors, Dr. Bluestone has held significant leadership roles at UCSF, including serving as the Director of the Immune Tolerance Network. His tenure as an executive vice chancellor and provost further highlights his dedication to fostering an environment of academic and scientific excellence. Dr. Bluestone's ongoing research efforts continue to push the boundaries of immunotherapy, with a focus on harnessing the potential of regulatory T cells to achieve immune tolerance. His work not only contributes to the scientific community but also holds promise for transforming the lives of patients facing challenging immune-related conditions.